Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies (Q36238764)

13 August 2017

Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies (English)

1 reference

13 August 2017

22

Brian Van Ness

0 references

author name string

Edmund C Lee

1

1 reference

13 August 2017

Michael Fitzgerald

2

1 reference

13 August 2017

Bret Bannerman

3

1 reference

13 August 2017

Jill Donelan

4

1 reference

13 August 2017

Kristen Bano

5

1 reference

13 August 2017

Jennifer Terkelsen

6

1 reference

13 August 2017

Daniel P Bradley

7

1 reference

13 August 2017

Ozlem Subakan

8

1 reference

13 August 2017

Matthew D Silva

9

1 reference

13 August 2017

Ray Liu

10

1 reference

13 August 2017

Michael Pickard

11

1 reference

13 August 2017

Zhi Li

12

1 reference

13 August 2017

Olga Tayber

13

1 reference

13 August 2017

Ping Li

14

1 reference

13 August 2017

Paul Hales

15

1 reference

13 August 2017

Mary Carsillo

16

1 reference

13 August 2017

Vishala T Neppalli

17

1 reference

13 August 2017

Allison J Berger

18

1 reference

13 August 2017

Erik Kupperman

19

1 reference

13 August 2017

Mark Manfredi

20

1 reference

13 August 2017

Joseph B Bolen

21

1 reference

13 August 2017

Brian Van Ness

22

1 reference

13 August 2017

Siegfried Janz

23

1 reference

13 August 2017

language of work or name

English

0 references

publication date

8 September 2011

1 reference

13 August 2017

Clinical Cancer Research

1 reference

13 August 2017

17

1 reference

13 August 2017

23

1 reference

13 August 2017

7313-7323

1 reference

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Proteasome inhibitors in cancer therapy: lessons from the first decade

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Maximizing mouse cancer models

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Murine models to evaluate novel and conventional therapeutic strategies for cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The use of targeted mouse models for preclinical testing of novel cancer therapeutics.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The mighty mouse: genetically engineered mouse models in cancer drug development

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Drug discovery in the ubiquitin-proteasome system.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Contributions of human tumor xenografts to anticancer drug development

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The development of proteasome inhibitors as anticancer drugs

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Potential for proteasome inhibition in the treatment of cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Proteasome inhibitors as new anticancer drugs

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Cancer modeling in the modern era: progress and challenges

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The ubiquitin-proteasome pathway: on protein death and cell life

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Application of surface roughness analysis on micro-computed tomographic images of bone erosion: examples using a rodent model of rheumatoid arthritis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443972

Genomic segmental polymorphisms in inbred mouse strains

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21903769

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of biochemical and biological effects of ML858 (salinosporamide A) and bortezomib

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21903769

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-11-0636

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

21903769

1 reference